Back
Sage Therapeutics Stock Price Chart

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
26
SAGE
Sage Therapeutics
Last Price:
$6.51
Seasonality Move:
-5.2%
7 Day Trial
ALL ACCESS PASS
$
7

Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing selling pressure, which indicates risk of future bearish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.77 | Sell |
20-day SMA: | 6.88 | Sell |
50-day SMA: | 7.35 | Sell |
200-day SMA: | 7.01 | Sell |
8-day EMA: | 6.7 | Sell |
20-day EMA: | 6.88 | Sell |
50-day EMA: | 7.11 | Sell |
200-day EMA: | 8.5 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 39.48 | Sell |
Chaikin Money Flow: | -639538 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.6 - 7.5) | Sell |
Bollinger Bands (100): | (6.54 - 7.82) | Sell |
Sage Therapeutics Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 6.52 while SAGE 8-day simple moving average is 6.77, which is a Sell signal.
-
The stock price of SAGE is 6.52 while Sage Therapeutics 20-day SMA is 6.88, which makes it a Sell.
-
Sage Therapeutics 50-day simple moving average is 7.35 while SAGE share price is 6.52, making it a Sell technically.
-
SAGE stock price is 6.52 and Sage Therapeutics 200-day simple moving average is 7.01, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
26
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a SellThe current Sage Therapeutics [SAGE] share price is $6.52. The Score for SAGE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
408.3M
Price in USD:
6.52
Share Volume:
806.7K
Sage Therapeutics 52-Week Range
52-Week High:
13.47
52-Week Low:
4.62
Sell
26
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?The Sage Therapeutics stock price is 6.52 USD today.
-
Will SAGE stock go up or go down?Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sage Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 6.52 while SAGE 8-day exponential moving average is 6.70, which is a Sell signal.
-
The stock price of SAGE is 6.52 while Sage Therapeutics 20-day EMA is 6.88, which makes it a Sell.
-
Sage Therapeutics 50-day exponential moving average is 7.11 while SAGE share price is 6.52, making it a Sell technically.
-
SAGE stock price is 6.52 and Sage Therapeutics 200-day simple moving average is 8.50, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.42 per share, an increase this year of $2.76 per share, and an increase next year of $0.46 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
-
SAGE Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Sage Therapeutics is a Sell
-
Sage Therapeutics Relative Strength Index (RSI) is 39.48, which suggest Sage Therapeutics is oversold
-
The Bollinger Bands (25) for Sage Therapeutics is (6.6 - 7.5), which suggest Sage Therapeutics is a Sell
-
The Bollinger Bands (100) for Sage Therapeutics is (6.54 - 7.82), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.